This discrepancy indicates a potential immune exemption and protection mechanism in the central nervous system, signifying that LRRK2 may fundamentally regulate the systemic immune inflammation in the TAA-HE model through peripheral regulation and that the observed high mortality rate of the model may be attributed to peripheral rather than cerebral causes. The gene discussed is LRRK2; the disease is hereditary elliptocytosis.